Subscribe to Newsletter

Dalvir Gill

The Power List 2018 – Champions of Change

Dalvir Gill

Chief Executive Officer and Member of the Board of Directors, TransCelerate Biopharma

Dalvir Gill was appointed CEO of TransCelerate in January 2013 and has since pioneered a number of changes and improvements to the drug development process. As the CEO of TransCelerate and its subsidiary BioCelerate, Dalvir has led a number of initiatives that have helped to make the research and development ecosystem more efficient, safe and innovative. Through TransCelerate, he has made it a priority to not only engage with patients about clinical trials, but to also offer higher value to patients and other healthcare stakeholders through more effective use of trial information.

Part of the Power List 2018

The World’s Top 100 Medicine Makers

Bringing new drugs to patients is an incredibly difficult task that involves numerous indispensable actors – from pioneering entrepreneurs and CEOs, to industry experts, to dedicated researchers, to regulators who keep everyone on the right tracks.

Go to The Power List 2018

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine